Bare metal stent thrombosis in patients with acute coronary syndrome

Fathia Mghaieth Zghal1, Aymen Amri, Mohamed Sami Mourali

  • 1Cardiology Department, Rabta Hospital of Tunis, Tunis, Tunisia. fathiazghal@yahoo.com

Insights

Stent thrombosis (ST) incidence is higher in acute coronary syndrome (ACS) patients undergoing stenting. Key predictors include fever during PCI, premature clopidogrel cessation, and smoking resumption, highlighting the need for improved patient education and secondary prevention.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • Patients with acute coronary syndrome (ACS) face elevated risks of stent thrombosis (ST) post-coronary stenting compared to elective procedures.
  • Limited research exists on ST incidence and predictors specifically within the ACS patient population.

Purpose of the Study:

  • To determine the incidence of definite stent thrombosis (ST) in patients with acute coronary syndrome (ACS) undergoing coronary stenting.
  • To identify independent predictors of ST in this high-risk patient group.

Main Methods:

  • A single-center study involving 611 consecutive Tunisian patients with ACS who received bare metal stents (BMS).
  • Follow-up was conducted for a median of 16 months to assess Academic Research Consortium (ARC) definite ST.
  • Statistical analysis identified independent predictors using hazard ratios (HR) and 95% confidence intervals (95%CI).

Main Results:

  • The overall incidence of ARC definite ST was 3.5%.
  • Patients with ST-elevation myocardial infarction (STEMI) undergoing emergency percutaneous coronary intervention (PCI) had a higher ST incidence of 9.2%.
  • Independent predictors of ST included fever during PCI, premature clopidogrel cessation, smoking resumption, primary PCI, rescue PCI, smaller reference vessel diameter (<2.8mm), poor pre-PCI TIMI flow (<2), and visible thrombus.

Conclusions:

  • The incidence of ST in ACS patients is notably higher than previously reported.
  • Premature discontinuation of clopidogrel and resuming smoking post-PCI are significant contributing factors to ST.
  • Enhanced patient education and secondary prevention strategies are crucial for mitigating ST risk in ACS patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...